$-0.90 EPS Expected for Anthera Pharmaceuticals (ANTH); Interdigital (IDCC) Has 1.59 Sentiment

October 12, 2017 - By Louis Casey

Analysts expect Anthera Pharmaceuticals Inc (NASDAQ:ANTH) to report $-0.90 EPS on November, 3.They anticipate $3.98 EPS change or 81.56% from last quarter’s $-4.88 EPS. After having $-0.86 EPS previously, Anthera Pharmaceuticals Inc’s analysts see 4.65% EPS growth. The stock decreased 5.00% or $0.09 on October 12, reaching $1.71. About 340,813 shares traded. Anthera Pharmaceuticals Inc (NASDAQ:ANTH) has declined 93.94% since October 12, 2016 and is downtrending. It has underperformed by 110.64% the S&P500.

InterDigital, Inc. designs and develops technologies for wireless communications. The company has market cap of $2.59 billion. The Firm is focused on three technology areas: cellular wireless technology, Internet of things technology, and, through its Hillcrest Laboratories, Inc. (Hillcrest Labs) subsidiary, sensor and sensor fusion technology. It has a 8.1 P/E ratio. It offers a range of technologies that are used in digital cellular and wireless products and networks, including second generation (2G), third generation (3G), fourth generation (4G) and IEEE 802-related products and networks.

Anthera Pharmaceuticals, Inc. is a biopharmaceutical firm focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases. The company has market cap of $18.65 million. The Firm has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. It currently has negative earnings. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions.

Among 6 analysts covering Anthera Pharmaceuticals (NASDAQ:ANTH), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Anthera Pharmaceuticals had 15 analyst reports since August 13, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Monday, June 26 with “Hold”. The firm earned “Hold” rating on Thursday, December 29 by Jefferies. Citigroup downgraded Anthera Pharmaceuticals Inc (NASDAQ:ANTH) on Thursday, December 29 to “Neutral” rating. On Wednesday, September 9 the stock rating was initiated by Suntrust Robinson with “Buy”. Zacks upgraded Anthera Pharmaceuticals Inc (NASDAQ:ANTH) rating on Thursday, August 13. Zacks has “Hold” rating and $11 target. On Thursday, December 29 the stock rating was maintained by H.C. Wainwright with “Buy”. The company was maintained on Sunday, August 6 by Jefferies. The firm earned “Overweight” rating on Thursday, December 29 by Piper Jaffray. The firm earned “Buy” rating on Friday, February 19 by Jefferies. H.C. Wainwright initiated the stock with “Buy” rating in Friday, July 8 report.

Permit Capital Llc holds 3.78% of its portfolio in InterDigital, Inc. for 83,116 shares. Fort L.P. owns 162,960 shares or 3.14% of their US portfolio. Moreover, Smithbridge Asset Management Inc De has 2.93% invested in the company for 46,000 shares. The Florida-based Camarda Financial Advisors Llc has invested 1.63% in the stock. Freestone Capital Holdings Llc, a Washington-based fund reported 253,888 shares.

Analysts await InterDigital, Inc. (NASDAQ:IDCC) to report earnings on October, 26. They expect $0.67 earnings per share, down 77.59% or $2.32 from last year’s $2.99 per share. IDCC’s profit will be $23.21 million for 27.89 P/E if the $0.67 EPS becomes a reality. After $1.46 actual earnings per share reported by InterDigital, Inc. for the previous quarter, Wall Street now forecasts -54.11% negative EPS growth.

The stock decreased 0.60% or $0.45 during the last trading session, reaching $74.75. About 371,224 shares traded or 18.34% up from the average. InterDigital, Inc. (IDCC) has risen 50.23% since October 12, 2016 and is uptrending. It has outperformed by 33.53% the S&P500.

Ratings analysis reveals 0 of Interdigital Comm’s analysts are positive. Out of 3 Wall Street analysts rating Interdigital Comm, 0 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. IDCC was included in 3 notes of analysts from September 9, 2016. Barclays Capital maintained the stock with “Equal Weight” rating in Friday, September 9 report. On Wednesday, December 7 the stock rating was downgraded by Sidoti to “Neutral”. The firm earned “Neutral” rating on Wednesday, October 5 by Dougherty & Company.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Louis Casey




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: